ArticleEJHaem2025

Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas.

Kensuke Yanashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.